Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia/lymphoma

Tatsuro Jo(Japanese Red Cross Society, Japan), Ritsuko Kubota‐Koketsu(The University of Osaka), Kuniko Abe(Japanese Red Cross Society, Japan), Jun Taguchi(Japanese Red Cross Society, Japan), Kaori Matsuzaka(Japanese Red Cross Society, Japan), Haruna Shioya(Japanese Red Cross Society, Japan), Takahiro Sakai(Japanese Red Cross Society, Japan), Masatoshi Matsuo(Japanese Red Cross Society, Japan), Hiro-o Tominaga(Japanese Red Cross Society, Japan), Shizuka Hayashi(Japanese Red Cross Society, Japan), Yohei Kaneko(Japanese Red Cross Society, Japan), Kazuto Shigematsu(Japanese Red Cross Society, Japan)
Anticancer Research
September 1, 2020
Cited by 13


Related Papers